EDAP TMS SA/ US2683111072 /
2024-03-18 5:08:03 PM | Chg. -0.11 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
7.32USD | -1.42% | 171 Turnover: 1,257.30 |
-Bid Size: - | -Ask Size: - | 7.57 | 7.32 |
GlobeNewswire
03-13
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
GlobeNewswire
03-06
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
GlobeNewswire
03-04
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrat...
GlobeNewswire
02-01
EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the T...
GlobeNewswire
01-08
EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
GlobeNewswire
01-02
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Account...
GlobeNewswire
2023-12-12
EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS...
GlobeNewswire
2023-11-30
EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Prope...
GlobeNewswire
2023-10-26
EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023
GlobeNewswire
2023-09-06
EDAP to Present at Morgan Stanley Annual Global Healthcare Conference and the H.C. Wainwright Annual...
GlobeNewswire
2022-03-21
EDAP TMS SA to Announce Fourth Quarter 2021 Financial Results on Wednesday, March 30, 2022
GlobeNewswire
2022-01-13
EDAP Announces Publication of Positive Pre-clinical Results Using Intraoperative HIFU Ablation of th...
GlobeNewswire
2021-11-29
EDAP to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
GlobeNewswire
2021-11-10
EDAP TMS SA to Announce Third Quarter 2021 Financial Results on Wednesday, November 17, 2021
GlobeNewswire
2021-09-28
EDAP Announces University of Washington Medicine to Launch Focal One® Robotic HIFU Program